The Department of Justice has recommended reclassifying cannabis to a lower-risk substance, a move long awaited by the marijuana industry. This recommendation could bring significant changes to cannabis-related real estate, including loosened lending restrictions and more available financing for facilities and growth.
Potential Impact on Cannabis Industry
The potential reclassification from Schedule 1 to Schedule 3 under the Controlled Substance Act could lead to improvements in banking access and regulatory barriers, spurring growth in the industry. Currently, the lack of banking access remains a significant challenge for cannabis businesses.
Revenue Potential and Legalization
Legal marijuana revenue is substantial, with states collecting nearly $3 billion in 2022. National legalization could generate $8.5 billion annually. However, access to banking and commercial property remains a hurdle for the industry.
Banking Access and Real Estate
The cannabis industry's access to banking affects its ability to secure commercial property. Banks often dictate lease terms, reflecting their cautious approach due to the drug's federal classification. Zoning regulations also impact where cannabis businesses can operate.
Impact on Real Estate Market
In Denver, cannabis businesses have influenced the industrial real estate market, occupying warehouse space. However, the potential reclassification may not have an immediate impact on commercial real estate, although it could reduce stigma and open up new opportunities.
Challenges Beyond Banking
Beyond banking access, cannabis businesses face challenges such as zoning restrictions, insurance costs, and meeting federal manufacturing standards. Rescheduling cannabis could also alleviate tax burdens imposed by Section 280E of the U.S. tax code.
Potential Benefits of Reclassification
Rescheduling cannabis could provide relief from high tax rates, allowing businesses to take deductions similar to other industries and reducing their effective tax rate.
Got News?